Merck & Company, Inc. vs Mettler-Toledo International, I — Stock Comparison
Q·Score Breakdown
6.7
Neutral
Overall
6.9
Neutral
Quality
Health
Growth
Valuation
Sentiment
MRK
Forward P/E of 11.5× is low relative to sector peers.
MTD
Earnings growing 17% year-over-year on 8% revenue growth.
Analyst Consensus
BUY
Target $129.74 (+15.7%)
27 analysts
HOLD
Target $1488.31 (+17.5%)
13 analysts
Fundamentals
MRK
MTD
31.5×
Trailing P/E
30.1×
11.5×
Forward P/E
24.7×
13.6%
Profit Margin
21.6%
76.6%
Gross Margin
59.4%
—
ROE
—
4.9%
Revenue Growth
8.1%
—
Earnings Growth
17.0%
0.28
Beta
1.44
—
Price / Book
—
$277.0B
Market Cap
$25.7B
$73 – $125
52-Week Range
$1,052 – $1,525
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →